n = 11,950 RCC patients | DVTb(n = 990) | P-Value | PEb(n = 286) | P-Value | OTEb(n = 470) | P-Value |
---|---|---|---|---|---|---|
HR (95% CI) | HR (95% CI) | HR (95% CI) | ||||
Male sex | 0.8 (0.7-0.9) | <0.001 | 0.8 (0.6- 1.0) | 0.041 | -- | -- |
Atherosclerosis | 2.0 (1.7-2.3) | <0.001 | 2.5 (2.0-3.2) | <0.001 | 1.7 (1.4-2.1) | <0.001 |
Diabetes | 1.2 (1.1-1.4) | 0.004 | -- | -- | -- | -- |
Hypercholesterolemia | -- | -- | -- | -- | 1.3 (1.1-1.6) | 0.012 |
Kidney disease | 1.9 (1.6-2.1) | <0.001 | 1.6 (1.2- 2.0) | <0.001 | 1.4 (1.2-1.7) | 0.001 |
Varicose veins | 2.2 (1.6-3.1) | <0.001 | -- | -- | -- | -- |
History of cancer diagnosis | -- | -- | 1.5 (1.0- 2.2) | 0.033 | -- | -- |
History of VTEc | 5.4 (4.4-6.4) | <0.001 | 20.1 (13.8-29.2) | <0.001 | 7.6 (5.9-9.9) | <0.001 |
Chemotherapy | 1.8 (1.4-2.2) | <0.001 | -- | -- | 1.4 (1.0-2.0) | 0.048 |
Central venous catheterd | 0.4 (0.3-0.4) | <0.001 | 0.3 (0.2-0.5) | <0.001 | 0.5 (0.4-0.7) | <0.001 |
High-risk surgerye | 0.4 (0.3-0.6) | <0.001 | 0.5 (0.3-0.8) | 0.003 | 0.5 (0.4-0.7) | <0.001 |
Stage | ||||||
Regional versus localized | 2.5 (2.2-2.9) | <0.001 | 1.6 (1.2-2.1) | 0.002 | 2.6 (2.1-3.2) | <0.001 |
Distant versus localized | 2.6 (2.2-3.0) | <0.001 | 1.9 (1.4-2.5) | <0.001 | 1.7 (1.3-2.2) | <0.001 |